Drugmakers Afflicted by Greek Pain With or Without Euro

A Greek exit from the euro would further depress drug prices throughout Europe, creating an additional dilemma for manufacturers already wrestling with how to keep supplies flowing as Greek health-care funds dry up.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.